Dr. Natalya Gudz, head of the State Service of Ukraine on Medicines and Drugs Control (SMDC), provides her vision for the development of Ukraine’s key regulatory authority and the win-win relationship she wants to bolster between the pharmaceutical and healthcare companies operating in Ukraine and SMDC’s international counterparts.
You took over the helm of the SMDC in December 2016. What have been your first priorities since your appointment at the head of this key regulatory authority in Ukraine?
"After years of instability, pharmaceutical companies are looking for clear, long-lasting rules, requirements, and controls that are acceptable to both sides."
